Join our community of smart investors

Tate & Lyle - not so sweet

Various wide-ranging issues mean that shares in Tate & Lyle are not that sweet
August 25, 2016

Everyone enjoys a sweet treat, but, on close examination, shares in Tate & Lyle (TATE) may be anything but. First up is an issue of which everyone is aware, but no one is sure of its impact - the lifting of sugar quotas in Europe in 2017. True, Tate is no longer linked to the eponymous brand that still figures prominently on supermarket shelves, but the removal of quotas also applies to isoglucose, or high-fructose corn syrup, which is a key part of its products stable.

IC TIP: Sell at 739p
Tip style
Sell
Risk rating
High
Timescale
Long Term
Bull points
  • Director buying shares
  • Weakness of sterling
Bear points
  • Performance goals for 2020 look ambitious
  • Plant relocation massaged sucralose profits
  • European quotas to be removed in 2017

The removal of quotas has the potential to see global supply rise and thus push down prices. Not only this, but group sales were 3 per cent down in constant currency in the 2015-16 financial year, reflecting the pass-through of lower corn prices. In the past year, corn prices have fallen roughly 18 per cent.

 

 

In a bid to diversify, management has outlined plans to enhance Tate's speciality food ingredients business, which it sees as its long-term growth driver. The aim is that the division will contribute 70 per cent of group profits, but in 2015-16 its progress was marginal, taking the share to just 60 per cent. This means significant growth will be needed in the next few years and a delay in achieving this goal could put pressure on the share price. Management also wants 30 per cent of sales to come from emerging markets. Yet this only stood at 21 per cent in 2015-16; again, some serious growth needs to be achieved.

While its Splenda sucralose business, which sits within the speciality foods division, has been reconfigured in a bid to improve a downward trend, the outlook still isn't upbeat. In May, Tate's bosses said they still expected a double-digit percentage decline in volumes for the current financial year because "industry capacity remains well in excess of demand and we expect this will lead to continued pricing pressure". That was disappointing because the rate of decline in Splenda's selling prices had slowed and costs had been reduced by closing the Singapore facility and bringing all manufacturing to the Alabama site.

The company registers a third of its speciality food division's sales in the US, but even the translation of the accounts into the now-weaker sterling isn't all good news. True, it helps profits and management says that every 1 cent rise in the dollar's sterling value adds £1.3m to pre-tax profits. Yet it also adds to the group's net debt in sterling.

An important attraction of the shares is the dividend. True, some City analysts reckon that the payout, which generates a 3.8 per cent yield, is sustainable. Yet dividend cover is tight. For the current financial year it is forecast to be 1.4 times (see table), which is much less than the average for the FTSE 250 index of which Tate's shares are a component. Meanwhile, in 2015-16, Tate's free cash generation covered barely more than half the dividend's £130m cost.

Not that these factors have prevented four of Tate's directors from buying shares in the company recently. These include chief executive Javed Ahmed, who bought £200,000-worth of shares earlier this month, and recently appointed non-executive director Lars Frederiksen, who bought £105,000-worth in July.

TATE & LYLE (TATE)
ORD PRICE:739pMARKET VALUE:£3.45bn
TOUCH:739-740p12M HIGH / LOW:744p492p
FORWARD DIVIDEND YIELD:3.8%FORWARD PE RATIO:17
NET ASSET VALUE:220pNET DEBT:42%

Year to 31 MarTurnover (£bn)Pre-tax profit (£m)Earnings per share (p)Dividend per share (p)
20143.1532255.727.6
20152.3418432.028.0
20162.3619334.528.0
2017*2.6222739.528.0
2018*2.7425544.228.0
% change+4+12+12nil

Normal market size: 3,000

Matched bargain trading

Beta: 0.8

*Numis forecasts (underlying profits & EPS)